Publikationen

Originalarbeiten (Autoren des NZN unterstrichen)
Five cases of Kaposi´s sarcoma in kidney graft recipients: possible influence of the immunosuppressive therapy. Kliem, V., Boeck, A, Eisenberger, U., Petersen, R., Radermacher, J., Hiß, M., Pethig, M., Koch, K.M., Nashan, B., Brunkhorst, R.: Treatment of chronic renal allograft failure by addition of mycophenolate mofetil: Single-center experience in 40 patients. Eberhard, O.K., Pötschik, H., Neumann, K.H., Kliem, V., Brunkhorst, R.: Short- and long-term effects of fish oil on proteinuria, morphology and renal hemodynamics in the Milan normotensive rat model of spontaneous Kidney Blood Press. Res. 22: 128-134, 1999 Kliem, V., Radermacher, J., Hiß, M., Pethig, M., Burg, M., Brunkhorst, R.: Conversion to tacrolimus for of acute corticosteroid- and antibody- resistant rejection following kidney transplantation. Transplant. Proc. 31 (Suppl. 7A): 37S-40S, 1999 Neumayer, H.-H., Paradis, K., Korn, A., Jean, C., Fritsche, L., Budde, K., Winkler, M., Kliem, V., Pichlmayr, R., Hauser, I.A., Burkhardt, K., Lison, A.-E., Barndt, I., Appel-Dingemanse, S.: Entry-into-human study with the novel immunosuppressant SDZ RAD in Brit. J. Clin. Pharmacol. 48: 694-703, 1999 Widjaja, A., Kielstein, J.T., Horn, R., von zur Mühlen, A., Kliem, V., Free serum leptin but not bound leptin concentrations are elevated in Nephrol. Dial. Transplant. 15: 846-850, 2000 Kliem, V., Burg, M., Radermacher, J., Hoffmann, M.W., Profound drop of cyclosporin A whole blood trough levels caused by St. Lonnemann, G., Floege, J., Kliem, V., Brunkhorst, R., Koch, K.M.: Extended daily veno-venous high-flux haemodialysis in patients with acute renal failure and multiple organ dysfunction syndrome using a Nephrol. Dial. Transplant. 15: 1189-1193, 2000 Kielstein, J., Termühlen, L., Sohn, J., Kliem, V.: Minimal change nephrotic syndrome in a 65-year-old patient following Küster, J., Kliem, V., Brunkhorst, R., Nashan, B., Oldhafer, K., Native pyeloureterostomy after kidney transplantation: experience in 48 Kliem, V., Tusch, G., Dannenberg, B., Brunkhorst, R.: Renal transplantation in older adults - Is graft survival affected by age? A Radermacher, J., Chavan, A., Schäffer, J., Stoess, B., Vitzthum, A., Kliem, V., Rademaker, J., Bleck, J., Gebel, M.J., Galanski, M., Detection of significant renal artery stenosis with color Doppler sonography: combining extrarenal and intrarenal approaches to minimize Pohanka, E., Bechstein, W.-O., Berlakovich, G., Binet, I., Friemann, S., Heemann, U., Kliem, V., Sperschneider, H., Stangl, M., Ringe, B.: Dosierung und Monitoring von Tacrolimus in der Primärtherapie nach Tillmann, H.L., Chen, D,-F., Trautwein, C., Kliem, V., Gundrey, A., Berning-Haag, A., Böker, K.H.W., Kubicka, S., Pastucha, L., Stangel, W., Low frequency of HLA-DRB1*11 in hepatitis C virus induced end stage Bock, C.T., Buerke, B., Tillmann, H.L., Tacke, F., Kliem, V., Manns, M.P., Relevance of hepatitis B core gene deletions in patients after kidney Vanrenterghem, Y., Ponticelli, C., Morales, J.M., Abramowicz, D., Baboolal, K., Eklund, B., Kliem, V., Legendre, C., Sarmento, A.L.M., Prevalence and management of anemia in renal transplant recipients: A Brunkhorst, R., Lufft, V., Dannenberg, B., Kliem, V., Tusch, G., Pichlmayr, Improved survival in patients with type 1 diabetes mellitus after renal transplantation compared with hemodialysis: a case control study. Salvadori, M., Rosati, A., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Jeffery, J., Kliem, V., Oppenheimer, F., Pohanka, E., Tufveson, G. on behalf of the MOST International Study Group: One-year post-transplant renal function is a strong predictor of long-term kidney function: results from the Neoral®-MOST observational study. Lebranchu, Y., Halimi, J.M., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Jeffery, J., Kliem, V., Oppenheimer, F., Pohanka, E., Salvadori, M., Tufveson, G. on behalf of the MOST International Study Group: Delayed graft function: risk factors, consequences and parameters affecting outcome - results from MOST, a multinational observational Kliem, V., Fritsche, L., Haller, H., Suwelack, B., Abendroth, D., Fornara, P., Pietruck, F., Frei, U., Donauer, J., Lison, A.E., Michel, U., Ulbricht, B. Cyclosporine-based immunosuppressive strategies for kidney recipients - interim analysis of german data from the multinational observational study Burg, M., Kretzler, M., Banas, B., Gröne, H.J., Kliem, V.: BK virus associated nephropathy in native kidneys of a heart allograft Schmid, H., Nitschko, H., Gerth, J., Kliem, V., Henger, A., Cohen, C.D., Schlöndorff, D., Gröne, H.-J., Kretzler, M.: Polyomavirus DNA and RNA detection in renal allograft biopsies: results from a European multi-center study. Salvadori, M., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Tufveson, G., Rosati, A., Puig, X., Corbetta, G. on behalf of the MOST International Study Group: Impact of mycophenolate mofetil dose posttransplantation on 12-month renal function: analysis of the MOST database. Salvadori, M., Rosati, A., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Tufveson, G., Bertoni, E. on behalf of the MOST International Study Group: Estimated one-year glomerular filtration rate is the best predictor of long- term graft function following renal transplant. Salvadori, M., Rosati, A., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Tufveson, G., Bertoni, E. on behalf of the MOST International Study Group: Low 1-year cyclosporine microemulsion doses are associated with better 5-year renal graft function: an insight from MOST, a multinational Chapman, J., Bock, A., Dussol, B., Fritsche, L., Kliem, V., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Salvadori, M., Tufveson, G.: Follow-up after renal transplantation with organs from donors after Burg, M., Jäkel, D., Kiss, E., Kliem, V.: Majocchi´s granuloma following kidney transplantation. Tacrolimus in transplantation of the kidney. Communication 1. Tacrolimus in transplantation of the kidney. Communication 2. Nephrology (russian) 11 (4): 18-27, 2007 Tacrolimus in base immunosuppression after renal transplantation: Nephrology (russian) 11 (4): 95-98, 2007 Frei, U., Noeldeke, J., Fabrizii, V., Arbogast, H., Margreiter, R., Fricke, L., Voiculescu, A., Kliem, V., Ebel, H., Albert, U., Lopau, K., Schnuelle, P., Nonnast-Daniel, B., Pietruck, F., Offermann, R., Persijn, G., Bernasconi, Prospective age-matching in elderly kidney transplant recipients – a 5- year analysis of the Eurotransplant senior program. Kliem, V., Fricke, L., Wollbrink, T., Burg, M., Radermacher, J., Rohde, F.: Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial. Kliem, V., Burg, M., Haller, H., Suwelack, B., Abendroth, D., Fritsche, L., Fornara, P., Pietruck, F., Frei, U., Donauer, J., Lison, A.E., Michel, U.: Relationship of hepatitis B and C virus prevalences, risk factors, and outcomes in renal transplant recipients: analysis of german data. Canaud, B., Mingardi, G., Braun, J., Aljama, P., Kerr, P.G., Locatelli, F., Villa, G., van Vlem, B., McMahon, A.W., Kerloëguen, C., Beyer, U. and Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a Nephrol. Dial. Transplant. 23: 3654-3661, 2008 Fellström, B.C., Jardine, A.G., Schmieder, R.E., Holdass, H., Bannister, K., Beutler, J., Chae, D.W., Chevaile, A.; Aurora Study Group: Rosuvastatin and cardiovascular events in patients undergoing Kliem, V., Michel, U., Burg, M., Bock, A., Chapman, J., Dussol, B., Fritsche, L., Lebranchu, Y., Oppenheimer, F., Pohanka, E., Salvadori, M., Geographical prevalence, risk factors and impact of hepatitis B and hepatitis C after renal transplantation. Trappe, R., Hinrichs, C., Appel, U., Babel, N., Reinke, P., Neumayer, H.H., Budde, K., Dreyling, M., Dührsen, U., Kliem, V., Schüttrumpf, S., Hauser, I.A., Mergenthaler, H.G., Schlattmann, P., Anagnostopoulos, I., Treatment of PTLD with rituximab and CHOP reduces the risk of renal graft impairment after reduction of immunosuppression. Weithofer, P., Schott, W., Bosse, A., Gröne, H.-J., Kliem, V.: Nierenzellkarzinom: Ungewöhnliche Spätmetastasierung 14 und 23 Jahre Dtsch. Med. Wochenschr. 134: 1674-1676, 2009 David, S., Kümpers, P., Lukasz, A., Fliser, D., Martens-Lobenhoffer, J., Bode-Böger, S., Kliem, V., Haller, H., Kielstein, J.: Circulating angiopoietin-2 levels increase with progress of chronic kidney Nephrol. Dial. Transplant. 25: 2571-2576, 2010 Maier, T., Schwarting, A., Mauer, D., Ross, R.S., Martens, A., Kliem, V., Wahl, J., Panning, M., Baumgarte, S., Müller, T., Pfefferle, S., Ebel, H., Tenner-Racz, K., Racz, P., Schmid, M., Strüber, M., Wolters, B., Gotthardt, D., Bitz, F., Frisch, L., Pfeiffer, N., Fickenscher, H., Sauer, P., Rupprecht, C.E., Roggendorf, M., Haverich, A., Galle, P., Hoyer, J., Management and outcomes after multiple corneal and solid organ transplantations from a donor infected with rabies virus. Lorenzen, J., Krämer, R., Kliem V., Bode-Böger, S.M., Veldink, H., Haller, H.H., Fliser, D., Kielstein, J.T.: Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney Europ. J. Clin. Invest. 40: 294-300, 2010 Good, D.M., Zurbig, P., Argiles, A., Bauer, H.W., Behrens, G., Coon, J.J., Dakna, M., Decramer, S., Delles, C., Dominiczak, A.F., Ehrich, J.H., Eitner, F., Fliser, D., Frommberger, M., Ganser, A., Girolami, M.A., Golovko, I., Gwinner, W., Haubitz, M., Herget-Rosenthal, S., Jankowski, J., Jahn, H., Jerums, G., Julian, B.A., Kellmann, M., Kliem, V., Kolch, W., Krolewski, A.S., Luppi, M., Massy, Z., Melter, M., Neususs, C., Novak, J., Peter, K., Rossing, K., Rupprecht, H., Schanstra, J.P., Schiffer, E., Stolzenburg, J.U., Tarnow, L., Theodorescu, D., Thongboonkerd, V., Vanholder, R., Weissinger, E.M., Mischak, H., Schmitt-Kopplin, P.: Naturally occuring human urinary peptides for use in diagnosis of chronic Mol. Cell. Proteomics 9: 2424-2437, 2010 Kielstein, J.T., Veldink, H., Martens-Lobenhoffer, J., Haller, H., Burg, M., Lorenzen, J., Lichtinghagen, R., Bode-Böger, S.M., Kliem, V.: SDMA is an early marker of change of GFR after living related kidney Nephrol. Dial. Transplant. 26: 324-328, 2011 Kielstein, J.T., Veldink, H., Martens-Lobenhoffer, J., Haller, H., Perthel, R., Lovric, S., Lichtinghagen, R., Kliem, V., Bode-Böger, S.M.: Unilateral nephrectomy causes an abrupt increase of inflammatory mediators and a simultaneous decrease in plasm ADMA – a study in Am. J. Physiol. Renal Pysiol. in press, 2011

Source: http://www.awogsd.de/uploads/Originalarbeiten.pdf

2008 volunteer attorney training calendar

2013 CALENDAR OF PHILADELPHIA EVENTS ABA NATIONAL PRO BONO CELEBRATION Pro Bono Road Shows When: September 30 through October 4, 2013 Where: Area Law Firms and Corporations What: Presentations by public interest agencies about their pro bono programs To schedule a Road Show, e-mail Jodi Schatz a SeniorLAW Center CLE Training: Saving Seniors’ Homes:

Takeda_rcp bn 8 pag

Riassunto delle caratteristiche del prodotto eventi avversi di fratture ossee riportati da studi clinici randomizzati, controllati, in doppio ciecoin oltre 8.100 pazienti trattati con pioglitazone e 7.400 trattati con farmaco di confronto per unperiodo superiore ai 3,5 anni, è stata osservata un’aumentata incidenza di fratture ossee nelledonne. Sono state osservate fratture nel 2,6% delle

Copyright ©2010-2018 Medical Science